T he paper "The Case for a Conservative Approach to Blood Transfusion Management in Cardiac Surgery" summarizes the current state of blood transfusion surrounding cardiac surgery. The authors raise the significant limitation in the current state of evidence and the existing challenges in identifying the subgroup of patients that should benefit the most from a strict or liberal blood transfusion protocol. The significance of a multidisciplinary or multimodality transfusion team is also highlighted. 1 Our ability to understand the positive and especially the negative impact of blood transfusion is fairly limited, as it is multifactorial and probably very difficult to isolate. As a prime example of the challenging problem is presented in the following perplexing comparison, how can we compare the potential impact of blood transfusion on outcome in a young low-risk patient that was transfused owing to perioperative bleeding with an elderly high-risk patient that presented for a complex surgery with a very low baseline hematocrit and multiple comorbidities? The paper presents the multiple challenges in understanding the appropriate indications and effect of blood transfusion in a very clear way. 1 One of the most important aspects of the review is the clarification that despite the lack of concrete evidence regarding the best universal approach to blood transfusion in cardiac surgery, there is a need for a protocol-driven approach on an institutional level so blood transfusion is standardized and its impact would be better understood. In our institution, we successfully implemented a multidisciplinary approach to blood transfusion. 2 This protocol was shown to be safe and very effective in controlling blood transfusion rates in our patients and therefore was adopted successfully statewide. 3 The outcome of cardiac surgery is multifactorial and beside patient complexity in many instances, it is institutional and surgeon dependent; therefore, generalizations of the impact of blood transfusion may not be possible. 4 This is why multicenter prospective randomized studies in cardiac surgery are very challenging. The inherent difference between centers may hamper understanding the real impact of the clinical intervention in question. When it comes to the impact of blood transfusion, a more granular approach should take place. The event of transfusion should be looked at in a more careful way, and different variables should be monitored diligently under any given protocol. Better understanding of the potential impact of the preoperative status of a patient and variables associated with higher blood transfusion rates such as preoperative hematocrit, BMI, sex, age, renal function, and albumin level should be taken into account. The type of surgery, surgeon experience, the cardiopulmonary bypass/cross clamp times, and hemodynamic state should be better stratified. The indications and the timing for transfusion should be carefully monitored. The indication for transfusion is of importance because if it is due to active bleeding, it is different from the need for higher hemoglobin levels to improve clinical status and inotropes requirement in a sick patient with a different physiologic
condition. The timing of transfusion is very important and should likely be assessed for potential differences in impact. It makes perfect sense that the timing, whether intraoperative, during the first 24 hours, first week, etc., have different effects on patients' outcome. Finally, the type of blood product given 5 may also demonstrate clinical significance.
The impact of transfusion on health-related quality of life should be also considered as a major outcome and a significant end point. 6 Our research shows that overall, health-related quality of life significantly improved in patients who received fewer units or were less likely to be transfused. Transfusion may cause micro-dysfunctions that alter normal physiologic function; therefore, blood conservation through a restrictive protocol could circumvent or lessen the possibility of dysfunction, thereby leading to a better quality of life (Ad N, Holmes SD, Patel J, et al. The impact of a multidisciplinary blood conservation protocol on patient outcomes and cost after cardiac surgery. Manuscript submitted for publication).
The review is very detailed in describing the current state of a lack of standardization in blood transfusion practice. The literature review is excellent and very balanced, as the authors are very careful in their assessment when it comes to clinical significance, and they highlight the complexity of the problem. The review highlights two of the most important aspects of blood management in cardiac surgery in which significant gaps exist. The first is the gap in appropriate scientific evidence and well-designed prospective randomized studies that would reflect on the current clinical practice. The second is the need to establish blood transfusion teams (multimodality) and protocols on an institutional level.
In summary, there is a need to design new prospective randomized studies that should take into account the potential modifiers that were mentioned earlier. The unique opportunity for process improvement and a multidisciplinary approach is well presented and discussed. Patients should be assessed continuously throughout the different phases of the perioperative period. Preoperative assessment and adjustments are often forgotten but may play a very important role in patients' outcome (Innovations consensus statement). Intraoperative management and standardization is lacking in most centers. Finally, postoperative management, where there is a lack of a protocol-driven approach may lead to significant variations in transfusion rates between different physicians even in the same institute. In our own center, we approached blood transfusion as recommended in the review with a multidisciplinary team and by allowing only an attending cardiac surgeon to approve transfusions. Since the program started, we were able to cut the intraoperative and postoperative blood transfusion rate in more than 50%, with only 24% of our all comer patients being transfused. Our transfusion rates for coronary artery bypass grafting are as low as 15% of patients with single-digit rates for elective cases. Our experience clearly demonstrates that lowering and standardizing transfusion rates is an achievable goal with significant cost savings. Clinically, our data suggest an improvement in multiple aspects of outcome to include renal failure, infections, length of stay, lower readmission rates, and better health-related quality of life.
